Meet Global Liver Institute at TLMdX 2020
Global Liver Institute (GLI) is dedicated to strengthening the alliance of patients, clinicians, and researcher communities to evolve the field of liver health. Join GLI at TLMdX to learn about our role in implementing the AASLD patient engagement strategy and GLI’s past, present and future advocacy and goals.
Join us for a session
Meet and Greet: Patient Advisory Committee Members and Your Hepatology Community
Friday, November 13, at 1:15pm ET
Donna Cryer, JD, President & CEO, Global Liver Institute (Committee Member)
Join an interactive session to welcome and introduce the inaugural Patient Advisory Committee Members. Learn how to nominate for upcoming community member opportunities on the Committee and with AASLD.
Advocating for Liver Disease: Experiences From the Field
Saturday, November 14th at 12:15pm ET
Andrew Scott, Director of Policy at Global Liver Institute (Speaker)
Learn best practices in liver health advocacy and hear about opportunities to participate in liver health advocacy with Congress, FDA and CMS. This session will include a live Q&A.
Interactive Patient-Focused Abstract Tour: Public Health/Public Equity/Health Care Delivery
Saturday, November 14th at 3:30 pm ET
Donna Cryer, JD, President & CEO, Global Liver Institute (Moderator/Guide)
Experience brief curated presentations of key public health/health equity/healthcare delivery posters presented at TLMdX.
AASLD Annual Patients Forum
Sunday, November 15th at 12:15pm ET
Donna Cryer, JD, President & CEO, Global Liver Institute (Co-Moderator)
AASLD leadership including President Jorge Bezerra, MD and Secretary Meena Bansal, MD welcome patient advocacy organization leaders and discuss patient engagement achievements and future areas for collaboration.
Access accepted posters co-authored by our CEO
Navigating AASLD
Patient / Advocate TLMdX Schedule
Join the dedicated Patients & Advocates discussion board so you can be kept updated in real-time, be in the know about sessions taking place, and interact with fellow attendees.
Listen to NASH-specific Meeting Analysis
Surfing The NASH Tsunami Podcast
The World's Leading Podcast for NASH and Fatty Liver Disease
“At GLI, our role in the liver community is to push and challenge the status quo. We have worked to develop an advocacy agenda that builds visibility for all people impacted by liver disease, and presses for policy makers, regulators, and world leaders to take liver health seriously.”
Donna Cryer, JD, President & CEO, Global Liver Institute